69
Views
5
CrossRef citations to date
0
Altmetric
LetterToEditor Article

Hypothalmic-Mediated Immune Mechanisms and Their Relevance to the Pathoettology of Parkinson's Disease

&
Pages 979-981 | Received 24 Feb 1986, Published online: 07 Jul 2009

References

  • Barden N., Dupont A., Labrie F., Merand Y., Roulear D., Vaudry H., Boissier, Jr. Age‐Dependent Changes in the Beta‐Endorphin Content of Discrete Rat Brain Nuclei. Brain Research 1981; 208: 209–212
  • Blalock J. E., Harbour‐McMenamin D., Smith E. M. Peptide Hormones Shared by the Neuro‐endocrine and Immunologic Systems. The Journal of Immunology 1985; 135: 858–861
  • Cotzias G. C., Van Woert M. H., Schiffer L. M. Aromatic Amino Acids and Modification of Parkinsonism. The New England Journal of Medicine 1967; 276: 384–379
  • Cross R. J., Markesbery W. R., Brooks W. H., Roszman T. L. Hypothalamic‐Immune Interactions. 1. The Acute Effect of Anterior Hypothalamic Lesions on the Immune Response. Brain Research 1980; 196: 79–87
  • Cuello A. C. Central Distribution of Opioid Peptides. British Medical Bulletin 1983; 39: 11–16
  • Cushing H. Selected Papers on the Pituitary Body, Hypothalamus and Parasympathetic Neuron System. Baltimore, Charles C. Thomas, Maryland 1932; 20–24
  • Ehrensing R. H., Kastin A. J., Larsons P. F., Bishop G. A. Melanocyte‐Stimulating Hormone Release Inhibiting Factor 1 and Tardive Dyskinesia. Diseases of the Nervous System 1977; 40: 303–306
  • Guy J., Vaudry H., Pelletier G. Identification of a Second Category of Alpha Melanocyte‐Stimulating Hormone (Alpha‐MSH) Neurons in the Rat Hypothalamus. Brain Research 1980; 199: 135–146
  • Hirano A., Zimmerman H. M. Alzheimer's Neurofibrillary Changes. A Topographic Study. Archives of Neurology 1962; 7: 227–242
  • Husby G., Li L., Davis L. E., Wedege E., Kokmen E., Williams R. C. Antibodies to Human Caudate Nucleus Neurons in Huntington's Chorea. Journal of Clinical Investigations 1977; 59: 922–932
  • Johnson R. T., Griffin D. E. Pathogenesis of Viral Infections. Handbook of Neurology‐Clinical Neurology, P. J. Vinken, G. W. Bruyen. Elsevier, Amsterdam 1978; 34: 15–34
  • Kastin A. J., Barbeau A. Preliminary Clinical Studies with L‐Prolyl‐L‐Leucyl‐Glycine Amide in Parkinson's Disease. Canadian Medical Association Journal 1972; 107: 1079–1081
  • Langston J. W., Forno L. S. The Hypothalamus in Parkinson's Disease. Annals of Neurology 1978; 3: 129–133
  • Pouplard A., Emile J., Pouplard F., Hurez D. Parkinsonism and Autoimmunity! Antibody against human Sympathetic Ganglion Cells in Parkinson's Disease. Advances in Neurology, L. F. Pokier, T. I‐. Sourkes, P. J. Bedard, 1979; 24: 321–326
  • Shuster S., Thody A. J., Goolamali S. K. Melanocyte‐stimulating Hormone and Parkinsonism. Lancet 1973; 2: 463–464
  • Van Loon G. R., Kim C. Beta‐Endorphin‐Induced Increase in Striatal Dopamine Turnover. Life Sciences 1978; 23: 961–970
  • Versteet D. H. G., De Crom M. P. G., Mulder A. H. ACTH‐(1–24) and Alpha‐MSH Antagonize Dopamine Receptor‐Mediated Inhibition of Striatal Dopamine and Acetylcholine Release. Life Sciences 1986; 38: 835–840
  • Wertman E., Ovadia H., Feldman S., Abramsky O. Prevention of Experimental Allergic Encephalomyelitis by Anterior Hypothalamic Lesion in the Rat. Neurology 1985; 35: 1468–1470

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.